ASH 2013: Dr. John Pagel Speculates on the Future of CLL (chronic lymphocytic leukemia) Therapies including the late breaking data on Idelalisib
ASCO is around the corner, but there is still important material to share from ASH.
Enjoy another video interview that offers confirmation on just how fast the world of CLL is changing.
Please see bkoffman.blogspot.com
I will be attending ASCO in a week and presenting both video and simple audio interviews there, plus my take on the latest news and abstracts.